BioSpace News Archive

Pharm Country

Saama’s Life Science Analytics Cloud Named One of the Most Innovative Products of 2017 by PM360

Saama’s Life Science Analytics Cloud was selected over hundreds of other entries to be part of PM360’s 6th Annual Innovations Issue, published each December.

December 18, 2017

·

4 min read

Drug Development

FDA Accepts Biologics License Application for Fremanezumab with Priority Review for Prevention of Migraine and Grants Fast Track Designation for Cluster Headache Development Program

Trial participant recruitment is now underway and the studies are expected to conclude in early 2019.

December 18, 2017

·

10 min read

Biotech Beach

ACEA Release: Real-Time Monitoring of Melanoma Cell Invasion Helps Scientists Elucidate Key Regulators of Metastasis

A team of Italian scientists reported this week that blocking the interaction between urokinase receptor (uPAR) and formyl peptide receptor type 1 (FPR1) suppresses the ability of melanoma cells to migrate, invade through an extracellular matrix, and to burrow through a layer of endothelial cells.

December 18, 2017

·

3 min read

Business

Applied DNA and Colorcon Announce Collaboration To Commercialize Product Authentication Technology for Pharmaceutical and Nutraceutical Industry

The MOU is non-binding and is expected to be followed by a definitive agreement.

December 18, 2017

·

5 min read

Policy

Alnylam and Sanofi Submit Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for Patisiran for the Treatment of Hereditary ATTR (hATTR) Amyloidosis

Alnylam announced today the submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for patisiran.

December 18, 2017

·

12 min read

Drug Development

Can-Fite Reports on the Progress of Its Phase II Liver Cancer With Namodenoson

The Company previously announced in August that it had successfully completed enrollment of 78 patients.

December 18, 2017

·

6 min read

Business

Globavir Announces Partnership With SingHealth Duke-NUS Academic Medical Centre to Study Dengue Treatment

Globavir Biosciences announced a partnership with the SingHealth Duke-NUS Academic Medical Centre in Singapore, through its newly established ViREMiCS, to conduct research for the treatment of dengue and chikungunya.

December 18, 2017

·

5 min read

Business

CEL-SCI Announces Robert Watson Joins Its Board of Directors

Mr. Watson has over 35 years of experience in the healthcare IT industry as a CEO, board member and advisor to multiple companies.

December 18, 2017

·

4 min read

Bausch + Lomb Begins Distribution of VYZULTA (Latanoprostene Bunod Ophthalmic Solution), 0.024% to U.S. Wholesalers

Valeant today announced that it has begun distributing VYZULTA.

December 18, 2017

·

3 min read

Policy

Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Approval of Yervoy (ipilimumab) for the Treatment of Pediatric Patients 12 Years and Older with Unresectable or Metastatic Melanoma

Bristol-Myers Squibb announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has recommended the approval of Yervoy (ipilimumab) for pediatric patients 12 years of age and older who have unresectable or metastatic melanoma.

December 18, 2017

·

17 min read